Taro Pharmaceutical Industries Ltd (NYSE:TARO)

139.17
Delayed Data
As of May 22
 -0.45 / -0.32%
Today’s Change
103.33
Today|||52-Week Range
173.00
-6.09%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Generic
MARKET CAP
$6.0B

Company Description

Taro Pharmaceutical Industries Ltd. engages in the development, manufacturing, and marketing of prescription and over-the-counter pharmaceutical products. Its products include topical creams, ointments, liquid, capsule, and tablet medications. It also involves in manufacturing and marketing of active drug ingredients for dermatological, cardiovascular and central nervous system therapeutic categories. The company was founded in 1950 and is headquartered in Haifa Bay, Israel.

Contact Information

Taro Pharmaceutical Industries Ltd.
14 Hakitor Street
Haifa Bay -- 26110
P:(724) 847-5700
Investor Relations:

Employees

Shareholders

Mutual fund holders2.03%
Other institutional10.90%
Individual stakeholders10.58%

Top Executives

Kal SundaramChief Executive Officer & Director
Michael KalbChief Financial & Accounting Officer, Group VP
Sharon AdlerVice President-Finance
Tzvi TalVice President-Information Technology
Avi AvramoffGlobal Vice President-Research & Development

To view my watchlist

Not a member yet?

Sign up now for a free account